Comparative Bioavailability of Risperidone
Clinical trial NCT03527186 · COMPLETED
Trial details
- NCT number
- NCT03527186
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2019-03-23
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.